featured
Reduced Acute Limb Ischemia With Rivaroxaban vs Placebo in Peripheral Artery Disease After Lower-Extremity Revascularization
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reduction in Acute Limb Ischemia with Rivaroxaban versus Placebo in Peripheral Artery Disease after Lower Extremity Revascularization: Insights from VOYAGER PAD
Circulation 2021 Oct 12;[EPub Ahead of Print], CN Hess, ES Debus, MR Nehler, SS Anand, MR Patel, M Szarek, WH Capell, J Hsia, JA Beckman, M Brodmann, R Diaz, P Habertheuer, NJ Leeper, RJ Powell, H Sillesen, E Muehlhofer, SD Berkowitz, LP Haskell, RM Bauersachs, MP BonacaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.